FDA OKs Drug Linked to Longer Survival in Fatal Genetic Disorder
(MedPage Today) -- The FDA approved adrabetadex (Lembaz) injection on Tuesday for patients with infantile-onset Niemann-Pick disease type C (NPC), a rare and fatal genetic disorder. Indicated for adults and children weighing at least 15 lb whose...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.